Induction of 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase type I gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13

Molecular Endocrinology

Volumn 13, Issue 1, 1999, Pages 66-81

  Gingras, Sébastien ^a   Moriggl, Richard ^b   Groner, Bernd ^b   Simard, Jacques ^a  

^a LAVAL UNIVERSITY   (Canada)

^b TUMOR BIOLOGY CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYSTEROID DEHYDROGENASE; INTERLEUKIN 13; INTERLEUKIN 4; ISOMERASE; 3 BETA HYDROXYSTEROID OXIDOREDUCTASE DELTA(5) 3 KETOSTEROID ISOMERASE; 3 BETA-HYDROXYSTEROID OXIDOREDUCTASE-DELTA(5) 3-KETOSTEROID ISOMERASE; 3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE; ANDROSTENEDIOL; ENZYME INHIBITOR; ESTROGEN RECEPTOR; MULTIENZYME COMPLEX; STAT6 PROTEIN; STAT6 PROTEIN, HUMAN; STAUROSPORINE; STEROID DELTA ISOMERASE; TRANSACTIVATOR PROTEIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; ENZYME INDUCTION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; BINDING SITE; BREAST; BREAST TUMOR; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PROMOTER REGION; UPREGULATION;

DNA VIRUSES; PAPOVAVIRIDAE;

ANDROSTENEDIOL; BASE SEQUENCE; BINDING SITES; BREAST; BREAST NEOPLASMS; CONSERVED SEQUENCE; ENZYME INHIBITORS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-13; INTERLEUKIN-4; MULTIENZYME COMPLEXES; PROGESTERONE REDUCTASE; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; STAT6 TRANSCRIPTION FACTOR; STAUROSPORINE; STEROID ISOMERASES; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032615619     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.13.1.66     Document Type: Article

References (77)

1. Bernstein L, Ross RK 1993 Endogenous hormones and breast cancer risk. Epidemiol Rev 15:48-65
2. Poulin R, Labrie F 1986 Stimulation of cell proliferation and estrogenic response by adrenal C19-delta 5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res 46:4933-4937
3. Poulin R, Baker D, Labrie F 1988 Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res Treat 12:213-225
4. Labrie F, Simard J, de Launoit Y, Poulin R, Theriault C, Dumont M, Dauvois S, Martel C, Li SM 1992 Androgens and breast cancer. Cancer Detect Prev 16:31-38
5. Adams JB 1985 Control of secretion and the function of C19-delta 5-steroids of the human adrenal gland. Mol Cell Endocrinol 41:1-17
6. Labrie F 1991 Intracrinology. Mol Cell Endocrinol 78:C113-118
7. Couillard S, Labrie C, Belanger A, Candas B, Pouliot F, Labrie F 1998 Effect of dehydroepiandrosterone and of the antiestrogen EM-800 on growth of human ZR-75-1 breast cancer xenografts. J Natl Cancer Inst 90:772-778
8. Labrie F, Diammond P, Cusan I, Gomaez L, Bélanger A, Candas B 1997 Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina and endometrium in postmenopausal women. J Clin Endocrinol Metab 82:3498-3505
9. Labrie F, Luu-The V, Lin S-X, Labrie C, Simard J, Breton R, Bélanger A 1997 The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology. Steroids 62:148-158
10. Simard J, Durocher F, Mebarki F, Turgeon C, Sanchez R, Labrie Y, Couet J, Trudel C, Rheaume E, Morel Y, Luu-The V, Labrie F 1996 Molecular biology and genetics of the 3 beta-hydroxysteroid dehydrogenase/Δ5-Δ4 isomerase gene family. J Endocrinol 150:S189-207
11. Simpson ER, Michael MD, Agarwal VR, Hinshelwood MM, Bulun SE, Zhao Y 1997 Expression of the CYP 19 (aromatase) gene: An unusual case of alternative promoter usage. FASEB J 11:29-36
12. Simard J, Rhéaume E, Sanchez R, Laflamme N, de Launoit Y, Luu-The V, van Seters AP, Gordon RD, Bettendorf M, Heinrich U, Moshang T, New MI, Labrie F 1993 Molecular basis of congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency. Mol Endocrinol 7:716-728
13. Rheaume E, Simard J, Morel Y, Mebarki F, Zachmann M, Forest MG, New MI, Labrie F 1992 Congenital adrenal hyperplasia due to point mutations in the type II 3β-hydroxysteroid dehydrogenase gene. Nat Genet 1:239-245
14. Thijssen JH, Blankenstein MA, Daroszewski J, Milewicz A 1990 Steroids in normal and neoplastic breast tissues. Ann NY Acad Sci 595:222-226
15. Reed MJ, Purohit A 1997 Breast cancer and the role of cytokines in regulating estrogen synthesis: An emerging hypothesis. Endocr Rev 18:701-715
16. Dickson RB, Lippman ME 1996 Autocrine, paracrine growth factors in the normal, neoplastic breast. In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the Breast. Lippincott-Raven Publishers, Philadelphia, pp 272-292
17. Kelly PM, Davison RS, Bliss E, McGee JO 1988 Macrophages in human breast disease: A quantitative immunohistochemical study. Br J Cancer 57:174-177
18. Whitford P, Mallon EA, George WD, Campbell AM 1990 Flow cytometric analysis of tumour infiltrating lymphocytes in breast cancer. Br J Cancer 62:971-975
19. Lorenzen J, Lewis CE, McCracken D, Horak E, Greenall M, McGee JO 1991 Human tumour-associated NK cells secrete increased amounts of interferon-gamma and interleukin-4. Br J Cancer 64:457-462
20. Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, Sehgal PB 1989 Interleukin- 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med 170:1649-1669
21. Danforth DN, Sgagias MK 1993 Interleukin-1α and inter-leukin- 6 act additively to inhibit growth of MCF-7 breast cancer cells in vitro. Cancer Res 53:1538-1545
22. Toi M, Bicknell R, Harris AL 1992 Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res 52:275-279
23. Paciotti GF, Tamarkin L 1988 Interleukin-1 directly regulates hormone-dependent human breast cancer cell proliferation in vitro. Mol Endocrinol 2:459-464
24. Blais Y, Sugimoto K, Carriere MC, Haagensen DE, Labrie F, Simard J 1995 Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1α on apolipoprotein D and GCDFP-15 expression in human breast cancer cells. Int J Cancer 62:732-737
25. Blais Y, Gingras S, Haagensen DE, Labrie F, Simard J 1996 Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. Mol Cell Endocrinol 121:11-18
26. Blais Y, Zhao C, Huber M, Audette M, Labrie F, Poulin R 1996 Growth-independent induction of spermidine transport by IL-4 and IL-13 in ZR-75-1 human breast cancer cells. Int J Cancer 67:532-538
27. Serve H, Oelmann E, Herweg A, Oberberg D, Serve S, Reufi B, Mucke C, Minty A, Thiel E, Berdel WE 1996 Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. Cancer Res 56:3583-3588
28. Adams EF, Rafferty B, White MC 1991 Interleukin 6 is secreted by breast fibroblasts and stimulates 17β-oestradiol oxidoreductase activity of MCF-7 cells: Possible paracrine regulation of breast 17β-oestradiol levels. Int J Cancer 49:118-121
29. Turgeon C, Gingras T, Carrière M-C, Blais Y, Labrie F, Simard J 1998 Regulation of sex steroid formation by interleukin-4 and interleukin-6 in breast cancer cells. J Steroid Biochem Mol Biol 6:151-162
30. Purohit A, Wang DY, Ghilchik MW, Reed MJ 1996 Regulation of aromatase and sulphatase in breast tumour cells. J Endocrinol 150:S65-71
31. Zhao Y, Nichols JE, Bulun SE, Mendelson CR, Simpson ER 1995 Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J Biol Chem 270:16449-16457
32. Obiri NI, Siegel JP, Varricchio F, Puri RK 1994 Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin Exp Immunol 95:148-155
33. Rochefort H, Garcia M 1984 The estrogenic and antiestrogenic activities of androgens in female target tissues. Pharmacol Ther 23:193-216
34. Simard J, Labrie C, Belanger A, Gauthier S, Singh SM, Merand Y, Labrie F 1997 Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro. Int J Cancer 73:04-12
35. Ihle JN 1996 STATs: Signal transducers and activators of transcription. Cell 84:331-334
36. Darnell Jr JE 1997 STATs and gene regulation. Science 277:1630-1635
37. Fenghao X, Saxon A, Nguyen A, Ke Z, Diaz Sanchez D, Nel A 1995 Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-gamma activation site-like sequence upstream of the I epsilon exon in a human B cell line. Evidence for the involvement of Janus kinase 3 and interleukin-4 Stat. J Clin Invest 96:907-914
38. Kohler I, Alliger P, Minty A, Caput D, Ferrara P, Holl Neugebauer B, Rank G, Rieber EP 1994 Human interleukin- 13 activates the interleukin-4-dependent transcription factor NF-IL4 sharing a DNA binding motif with ah interferon-gamma-induced nuclear binding factor. FEBS Lett 345:187-192
39. Quelle FW, Shimoda K, Thierfelder W, Fischer C, Kim A, Ruben SM, Cleveland JL, Pierce JH, Keegan AD, Nelms K, Paul WE, Ihle JN 1995 Cloning of murine Stat 6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not requirecl for mitogenesis. Mol Cell Biol 15:3336-3343
40. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL 1994 An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:1701-1706
41. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, Chu C, Quelle FW, Nosaka T, Vignali DA, Doherty PC, Grosveld G, Paul WE, Ihle JN 1996 Lack of IL-4-induced Th 2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630-633
42. Kaplan MH, Schindler U, Smiley ST, Grusby MJ 1996 Stat 6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313-319
43. Takeda K, Kamanaka M, Tanaka T, Kishimoto T, Akira S 1996 Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J Immunol 157:3220-3222
44. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, Nakanishi K, Yoshida N, Kishimoto T, Akira S 1996 Essential role of Stat 6 in IL-4 signalling. Nature 380:627-630
45. Takeda K, Kishimoto T, Akira S 1997 STAT6: Its role in interleukin 4-mediated biological functions. J Mol Med 75:317-326
46. Ohmori Y, Smith MF, Hamilton TA 1996 IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by stat6. J Immunol 157:2058-2065
47. Sasano H, Frost AR, Saitoh R, Harada N, Poutanen M, Vihko R, Bulun SE, Silverberg SG, Nagura H 1996 Aromatase and 17β-hydroxysteroid dehydrogenase type 1 in human breast carcinoma, J Clin Endocrinol Metab 81:4042-4046
48. Li S, Yan X, Bélanger A, Labrie F 1993 Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz[a]anthracene (DMBA) in the rat. Breast Cancer Res Treat 29:203-217
49. Sourla A, Martel C, Labrie C, Labrie F 1998 Almost exclusive androgenic action of dehydroepiandrosterone in the rat mammary gland. Endocrinology 139:753-764
50. Zurawski G, de Vries JE 1994 Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells, Immunol Today 15:19-26
51. Zurawski SM, Vega Jr F, Huyghe B, Zurawski G 1993 Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 12:2663-2670
52. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedmann MC, Miyajima A, Puri RK, Paul WE, Leonard WJ 1993 Interleukin-2 receptor gamma chain: A functional component of the interleukin-4 receptor. Science 262:1880-1883
53. Vita N, Lefort S, Laurent P, Caput D, Ferrara P 1995 Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J Biol Chem 270:3512-3517
54. Miloux B, Laurent P, Bonnin O, Lupker J, Caput D, Vita N, Ferrara P 1997 Cloning of the human IL-13R alpha 1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett 401:163-166
55. Gauchat JF, Schlagenhauf E, Feng NP, Moser R, Yamage M, Jeannin P, Alouani S, Elson G, Notarangelo LD, Wells T, Eugster HP, Bonnefoy JY 1997 A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor. Eur J Immunol 27:971-978
56. Caput D, Laurent P, Kaghad M, Lelias JM, Lefort S, Vita N, Ferrara P 1996 Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem 271:16921-16926
57. Lin JX, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET, Mietz J, John S, Leonard WJ 1995 The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2:331-339
58. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K 1992 Cytokine receptors and signal transduction. Annu Rev Immunol 10:295-331
59. Herbert JM, Savi P, Laplace MC, Lale A, Dol F, Dumas A, Labit C, Minty A 1993 IL-4 and IL-13 exhibit comparable abilities to reduce pyrogen-induced expression of procoagulant activity in endothelial cells and monocytes. FEBS Lett 328:268-270
60. Berton MT, Linehan LA 1995 IL-4 activates a latent DNA-binding factor that binds a shared IFN-gamma and IL-4 response element present inthe germ-line gamma 1 Ig promoter. J Immunol 154:4513-4525
61. Kotanides H, Reich NC 1996 Interleukin-4-induced stat 6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene. J Biol Chem 271:25555-25561
62. Delphin S, Stavnezer J 1995 Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: Regulation by NF-IL-4, a C/EBP family member and NF-kappa B/p50. J Exp Med 181:181-192
63. Keegan AD, Johnston JA, Tortolani PJ, McReynolds LJ, Kinzer C, O'Shea JJ, Paul WE 1995 Similarities and differences in signal transduction by interleukin 4 and interleukin 13: Analysis of Janus kinase activation. Proc Natl Acad Sci USA 92:7681-7685
64. White MF 1994 The IRS-1 signaling system. Curr Opin Genet Dev 4:47-54
65. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers Jr MG, Glasheen E, Lane WS, Pierce JH, White MF 1995 Role of IRS-2 in insulin and cytokine signalling. Nature 377:173-177
66. Kotanides H, Moczygemba M, White MF, Reich NC 1995 Characterization of the interleukin-4 nuclear activated factor/STAT and its activation independent of the insulin receptor substrate proteins. J Biol Chem 270:19481-19486
67. Pernis A, Witthuhn B, Keegan AD, Nelms K, Garfein E, Ihle JN, Paul WE, Pierce JH, Rothman P 1995 Interleukin 4 signals through two related pathways. Proc Natl Acad Sci USA 92:7971-7975
68. Patel BKR, Wang LM, Lee CC, Taylor WG, Pierce JH, Larochelle WJ 1996 Stat 6 and Jak1 are common elements in platelet-derived growth-factor and interleukin-4 signal-transduction pathways in NIH 3T3 fibroblasts. J Biol Chem 271:22175-22182
69. Seidel HM, Milocco LH, Lamb P, Darnell Jr JE, Stein RB, Rosen J 1995 Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity. Proc Natl Acad Sci USA 92:3041-3045
70. Mikita T, Campbell D, Wu P, Williamson K, Schindler U 1996 Requirements for interleukin-4-induced gene expression and functional characterization of Stat 6. Mol Cell Biol 16:5811-5820
71. Zhang Z, Jones S, Hagood JS, Fuentes NL, Fuller GM 1997 STAT 3 acts as a co-activator of glucocorticoid receptor signaling. J Biol Chem 272:30607-30610
72. Stocklin E, Wissler M, Gouilleux F, Groner B 1996 Functional interactions between stat 5 and the glucocorticoid receptor. Nature 383:726-728
73. Bhattacharya S, Eckner R, Grossman S, Oldread E, Arany Z, D'Andrea A, Livingston DM 1996 Cooperation of Stat 2 and p300/CBP in signalling induced by interferon-alpha. Nature 383:344-347
74. Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Darnell Jr JE 1996 Two contact regions between Stat 1 and CBP/p300 in interferon gamma signaling. Proc Natl Acad Sci USA 93:15092-15096
75. Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, Rose DW, Rosenfeld MG, Glass CK 1997 Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci USA 94:1074-1079
76. Moriggl R, Berchtold S, Friedrich K, Standke GJ, Kammer W, Heim M, Wissler M, Stocklin E, Gouilleux F, Groner B 1997 Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells. Mol Cell Biol 17:3663-3678
77. Schmitt Ney M, Doppler W, Ball RK, Groner B 1991 Beta-casein gene promoter activity is regulated by the hormone-mediated relief of transcriptional repression and a mammary-gland-specific nuclear factor. Mol Cell Biol 11:3745-3755